Latest Breaking News On - Drug administration for center - Page 1 : comparemela.com

YANTAI, China, Feb. 2, 2024 /PRNewswire/ RemeGen Co. Ltd.("RemeGen" or "the Company") (9995.HK, 688331.SH), a commercial-stage biotechnology company, with

Shen linUnited statesRemegen disitamab vedotinDisitamab vedotinInnovent biologicsJianmin fangUniversity cancer hospitalRemegen coUnion for international cancer controlLtd remegenDrug administration for centerScare gapWorld cancer dayState foodDrug administrationDrug evaluation